USA, July 10, 2019, (MARIJUANA BUSINESS DAILY)- The head of a cannabis industry lobbying group urged U.S. Congressional lawmakers Wednesday to pass legislation to protect state-legal marijuana businesses and resolve the “untenable” conflict between state and federal marijuana laws. Neal Levine, chief executive officer of the Cannabis Trade Federation, called …
Read More »Industry News
Colorado has made around $1bn from legal cannabis industry
London, June 13, 2019, (INDEPENDENT)- Colorado has made more than $1bn (£789m) since it legalised cannabis 2014, with more than 41,000 people now licensed to work in the industry. It is the latest milestone for the state which has been home to more than $6.5bn in total cannabis sales since legalisation. April, which includes …
Read More »New rules for medical cannabis in Israel
Users of the drug are skeptical that the new system will actually make it easier for patients to access medical cannabis. Israel, July 5, (THE JERUSALEM POST)- Cigarettes filled with medical cannabis are seen at Pharmocann, an Israeli medical cannabis company in northern Israel January 24, 2019. Picture taken January …
Read More »THC limit that will apply to such products is simply too low for many medical patients
Canda, June 30, (BOTANIQ)- The head of NICHE Canada says she was disappointed not to see any medical carve-out, or a different class or products for cannabis patients, in the recently revealed regulations for edibles in Canada. The 10 mg THC limit that will apply to such products is simply …
Read More »CBD as Natural Health Product
Montreal, June 21, 2019, (LEAFLY)- When a Health Canada representative told a media call last week the agency had “committed to conducting further consultations on the precise question of CBD as a Natural Health Product (NHP),” some expressed pessimism such consultations would arrive quickly. There were no timelines in last week’s new regulations …
Read More »FSD Pharma has acquired all outstanding shares of Prismic
USA, July 2, 2019, (PROACTIVE INVESTORS USA)- FSD Pharma also has agreed to assume approximately US$3.05 million of outstanding Prismic long- and short-term liabilities. FSD Pharma Inc (CSE: HUGE) (OTCMKTS:FSDDF) announced Tuesday it has closed on the deal to acquire US-based specialty research and development pharma company Prismic Pharmaceuticals Inc. The …
Read More »Alabama drugstores and CBD ingestibles
Pharmacies in Alabama now can join gas stations and other retailers cleared to flout federal restrictions on CBD products. A new law removing hemp from Alabama’s controlled-substances list allows pharmacies to carry CBD dietary supplements, something other retailers in Alabama already had been given permission to do. Pharmacies in Alabama said they …
Read More »The markets for industrial hemp are growing
CANADA, June 19, 2019 (GLOBAL NEWS)- The markets for industrial hemp are growing as people who attended Canada’s Farm Progress Show in Regina learned on Wednesday. Andrea Eriksson, a business development officer at NorQuest College, said it’s one of the fastest growing industries in North America. “It’s a very hearty crop,” Eriksson said. “It grows …
Read More »FSD Pharma Receives A Cannabis License From Health Canada
TORONTO, June 24, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”) has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license is effective as of June 21, 2019. The latest amendment to the license, originally granted on April …
Read More »FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers
TORONTO, May 20, 2019, Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA Join distinguished group of Scientific Advisors TORONTO, May 20, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), is pleased to announce that three eminent cannabis researchers have joined the company’s Scientific Advisory …
Read More »Disclaimer
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!